written on 20.05.2014
Tags:
,

Side effect analysis suggests Gilead's hep C wonder Sovaldi is safer than rivals, too

TAGS: ,

Gilead Sciences' breakthrough drug Sovaldi isn't just the newest hepatitis C drug to hit the market, or the fastest-selling. It's also the safest, according to an early analysis of adverse event reports.

Latest Report